NDC 72162-1813-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1813
- Requested NDC
- 72162-1813-01
- Package NDCs from labels
- 72162-1813-1, 72162-1813-2, 72162-1813-4, 72162-1813-6, 72162-1813-7, 72162-1813-8, 72162-1813-9, 72162-1813-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1813-1 | Gabapentin | 100 in 1 BOTTLE | CAPSULE | 100 | 103 | |
| 72162-1813-2 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 103 | |
| 72162-1813-4 | Gabapentin | 20 in 1 BOTTLE | CAPSULE | 20 | 103 | |
| 72162-1813-6 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 103 | |
| 72162-1813-7 | Gabapentin | 180 in 1 BOTTLE | CAPSULE | 180 | 103 | |
| 72162-1813-8 | Gabapentin | 84 in 1 BOTTLE | CAPSULE | 84 | 103 | |
| 72162-1813-9 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1813 | GABAPENTIN CAPSULE [BRYANT RANCH PREPACK] | 103 | Current NDC, 7 package rows | 20241122_7b404ab9-8a7e-49d4-920f-487875d14e45.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1813-1 | EA - Each | 72162-1813 | 8856c4e8-137b-44a5-808d-f98066f19826 | 1 | 2023-10-16 |
| 72162-1813-2 | EA - Each | 72162-1813 | a183c871-091d-44cf-9543-d7001ec1c283 | 1 | 2023-10-16 |
| 72162-1813-4 | EA - Each | 72162-1813 | b07e71dd-2f20-45ee-991b-6c6439d04975 | 1 | 2023-10-16 |
| 72162-1813-6 | EA - Each | 72162-1813 | 9e445edb-c461-4927-b6b3-e05adc58973d | 1 | 2023-10-16 |
| 72162-1813-7 | EA - Each | 72162-1813 | c96e5a2f-b40c-487c-ba7d-b9d07d0426c2 | 1 | 2023-10-16 |
| 72162-1813-8 | EA - Each | 72162-1813 | 67d0ac8a-2d12-4499-a0a3-e52e90e6285b | 1 | 2023-10-16 |
| 72162-1813-9 | EA - Each | 72162-1813 | ab614c8e-b9c9-4442-bd0b-61e9a0f3be0e | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 081fd1de-acaa-4685-a053-4959d77b17e9 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 0e1d17d5-d39c-4144-aac0-7c0d3bc9ec0d | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 2343e3a1-82d0-4c70-a086-a01a0ce81ef3 | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 67330eef-c976-4862-b1ae-20f30f43df76 | 2026-02-09 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 2e331641-ec26-4d76-b16b-a9863c767afe | 2026-02-06 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | cc1998a7-7004-4688-8b5b-525041851d1d | 2026-02-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 4aa69d04-6b32-4764-a48b-ef5313dd95d3 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 60b46f6d-efbc-487a-b672-b20df8b44cc4 | 2026-01-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 43a3ec78-8235-4d46-a343-2f9226745a39 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 685553b0-384e-400b-a8ae-612ceece8261 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 7ea0b220-edbb-45eb-aeb3-65283f8489a1 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | bff3beea-1f05-4e84-bcd2-d05782acddae | 2026-01-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | DIRECT RX | 29a70e2d-d3fd-4e32-95dd-7ee721d87388 | 2026-01-08 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| gabapentin | GABAPENTIN | Coupler LLC | 47cd25f6-e123-9aaf-e063-6394a90aeedd | 2026-01-07 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABARONE | GABAPENTIN | INA Pharmaceutics Inc. | 0f350a4b-f294-4b98-b69f-3cc789e930ba | 2026-01-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ajenat Pharmaceuticals LLC | 02304deb-7b4a-452f-9b1a-64ca0aedbcc2 | 2025-12-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Northwind Health Company, LLC | 471b2d32-0cbd-aade-e063-6394a90a1696 | 2025-12-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | ST. MARY'S MEDICAL PARK PHARMACY | 3aaf3d6e-c6d5-89f5-e063-6394a90a9b77 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Northwind Health Company, LLC | 47214c7c-ba1b-9107-e063-6294a90a5431 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | BioComp Pharma, Inc. | 0b3a4009-42f3-c84f-e063-6294a90a8068 | 2025-12-17 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.